The U.S. Food and Drug Administration (FDA) may not renew the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children under the age of five, the company said. The possible move would pull the only available coronavirus vaccine for young children from the market. "We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season," a spokesperson for Pfizer said in a statement to Fox News Digital."It is important to note that these deliberations are not related to the sa...

18 hours ago

On HALO